Business Development & Strategic Partnerships Manager; Payer Government Markets

About the Opportunity

Advanced cancer care is one of the highest-cost, most complex challenges facing U.S. healthcare payers today. Advanced-stage patients incur annual medical costs exceeding $100,000, yet many never receive guideline-adherent, personalized treatments. Massive Bio has built the only AI-powered oncology navigation platform that closes this gap at scale — combining real-time clinical trial matching, biomarker-driven decision support, and value-based care pathways into a single, payer-ready solution.

We are seeking a Manager, Business Development & Strategic Partnerships to drive our payer, employer, and government business development efforts. While we have existing partnerships in this channel, this role carries a strong build-and-execute mandate as we bring a new multi-agentic AI infrastructure to market. You will generate pipeline, develop target accounts, structure deal frameworks, and advance contracts across segments of the U.S. payer landscape — working closely with company leadership throughout the sales cycle.

This role also includes a government engagement dimension. Massive Bio has committed to the CMS “Kill the Clipboard” and Conversational AI pledges, and you will support the company's representation to CMS and federal agencies, helping ensure our platform is positioned within federal digital health modernization efforts.

The U.S. payer landscape represents a $4+ trillion ecosystem. Below is the market map you will be responsible for developing. These are early-stage or greenfield segments — you will play a central role in opening and advancing these relationships.

Support Massive Bio's engagements with the Centers for Medicare & Medicaid Services (CMS), including ongoing commitments to the “Kill the Clipboard” and Conversational AI pledges. Help position the platform for CMS Innovation Center (CMMI) models, Oncology Care Model successors, and federal demonstration projects involving AI-enabled navigation and clinical trial access. Develop working relationships with relevant HHS/ONC stakeholders to support regulatory alignment and contribute to the company's positioning around AI in oncology care delivery.

• United Health Group (United Healthcare)
• Elevance Health (formerly Anthem)
• CVS Health / Aetna
• The Cigna Group
• Centene Corporation
• Humana

The BCBS Association comprises 33 independent, locally operated companies. Consortium Health Plans is a critical aggregator enabling direct access to 20+ BCBS plans for national accounts. Priority independent Blues targets include:
Health Care Service Corporation (HCSC), Guidewell / Florida Blue, Highmark, Blue Shield of California, Independence Blue Cross (IBX), Care First Blue Cross Blue Shield.

• Kaiser Permanente
• UPMC Health Plan
• Geisinger Health Plan
• Intermountain Health / Select Health
• Providence Health Plan
• Spectrum Health / Priority Health

• Angle Health
• Oscar Health
• Alignment Healthcare
• Devoted Health
• Sana Benefits

Approximately 65% of all covered U.S. workers are in self-funded plans. Because these employers assume their own financial risk, market access requires a multi-pronged approach through TPAs, brokerages, and coalitions.

• UMR
• Meritain Health
• Collective Health
• HealthSCOPE Benefits
• Luminare Health

• Gallagher
• Brown & Brown
• Hub International
• USI Insurance Services
• Assured Partners
• Alliant Insurance Services
• IMA Financial Group
• Higginbotham
• One Digital
• Assurex Global
• Mc Griff
• Leavitt Group